0.05
-16.61%
Close of 4 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About CTT Pharmaceutical Holdings
From its filings with the US Securities and Exchange Commission
CTT Pharmaceutical Holdings is based in Tampa, Florida and is incorporated in Florida. Its shares trade on OTC under the ticker CTTH. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2014, it reported net income of $227,838. At that date it held total assets of $1.7m and shareholders' equity of $586,630.
Mindesta Inc. ("Mindesta," "the Company," "our" or "we") is a Delaware Corporation, was incorporated on November 6, 1996 under the name Winchester Mining Corp. The name of the Company was changed to PNW Capital, Inc. on May 16, 2000. In 2002, PNW Capital, Inc. acquired Industrial Minerals Incorporated, a private Nevada Corporation, and changed its name to Industrial Minerals, Inc. Effective July 26, 2011, the Company adopted the new name of "Mindesta Inc.". In conjunction with this action, the Company consolidated its stock on a 20:1 basis.
Due to financial difficulties and the inability to secure financing, the Company ceased operations in 2013.
The 149,183,285 restricted Mindesta common stock issued at closing represented approximately 80% of the then issued and outstanding common stock of Mindesta.
CTT is now a wholly owned subsidiary of Mindesta and is now the exclusive focus of Mindesta's business operations. Mindesta has abandoned all of its previous business operations. CTT Pharma is a development stage company with limited operations to date focused on developing an oral delivery system of medication contained on a disposable film.
Quoted from its 10-K, filed 14 Apr 2015. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 18 Apr 1997
- Website
- cttpharmaceuticals.com ↗
- Head office
- 1646 W. SNOW AVE SUITE 138, TAMPA, FL, 33606
- Incorporated in
- FL
- Classification
- Pharmaceutical Preparations
- Filer status
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Leadership
Pay as last reported
- Mr. William BirgePresident, Director, since 2006$18,018
- Dr. Pankaj ModiChief Executive Officer and Chief Science Officer, Director, since 2014
- Mr. Robert AllenChief Financial Officer
- Mr. Dean HanischTreasurer, Secretary, Director, since 2014
- Dr. Allen GreenspoonDirector
- Dana BuschmannIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- CTT Pharmaceutical Holdings Inc possesses several strengths that contribute to its competitive advantage:
Weaknesses
- Despite its strengths, CTT Pharmaceutical Holdings Inc has some weaknesses that pose challenges to its growth and success:
Opportunities
- CTT Pharmaceutical Holdings Inc can capitalize on the following opportunities to further strengthen its position in the market:
Threats
- CTT Pharmaceutical Holdings Inc faces several threats that could impact its growth and overall performance:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.